Sirolimus, Tacrolimus, Thymoglobulin and Rituximab as Graft-versus-Host-Disease Prophylaxis in Patients Undergoing Haploidentical and HLA Partially Matched Donor Hematopoietic Cell Transplantation
PHASE2
This Phase II clinical trial was designed for patients with hematologic mal...
Vaccine Therapy in Treating Patients Who Have Undergone a Donor Stem Cell Transplant and Have Cytomegalovirus Infection That Has Not Responded to Therapy
PHASE1
RATIONALE: Vaccines may help the body build an effective immune response to...
Status
Completed
Location
Penn State Hershey Cancer Institute at Milton S. Hershey Medical Center